logo

The CLDI Stock Puzzle: Unraveling Calidi Biotherapeutics Inc’s Fluctuating Performance

THMO

Calidi Biotherapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $16.90 on 12/26/23 and a low of $0.73 for the same time frame on 10/25/24.

52-week price history of CLDI Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Calidi Biotherapeutics Inc’s current trading price is -91.89% away from its 52-week high, while its distance from the 52-week low is 87.67%. The stock’s price range during this period has spanned from $0.73 to $16.90. In the Healthcare sector, the Calidi Biotherapeutics Inc’s shares surpassed a trading volume of approximately 1.37 million for the day, which was noticeably lower compared to the average daily volume of 9.1.56 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Market Capitalization and Financial Performance: An In-Depth Look

Calidi Biotherapeutics Inc (CLDI) has experienced a quarterly rise of 19.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.82M and boasts a workforce of 41 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4701, with a change in price of -0.1400. Similarly, Calidi Biotherapeutics Inc recorded 1,045,834 in trading volume during the last 100 days, posting a change of -9.15%.

CLDI Stock Stochastic Average

Today, Calidi Biotherapeutics Inc’s raw stochastic average for the past 50 days stands at 20.89%, indicating a rise from the raw stochastic average of the last 20 days, which was 11.62%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 11.30% and 9.20% respectively.

CLDI Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -90.93%. However, over the last six months, the performance has been stronger by -30.81%. The price of CLDI decreased -35.98% over the last 30 days. And in the last five days, it has fallen by -20.81%.

Most Popular